Copyright: ©Author(s) 2026.
World J Cardiol. Apr 26, 2026; 18(4): 117928
Published online Apr 26, 2026. doi: 10.4330/wjc.v18.i4.117928
Published online Apr 26, 2026. doi: 10.4330/wjc.v18.i4.117928
Table 3 Guideline-directed medical therapy prescription in the study population
| Population (n = 407) | n (%) |
| ACEI/ARB | 325 (79.85) |
| Ramipril | 280 (68.8) |
| Telmisartan | 33 (8.11) |
| Perindopril | 12 (2.94) |
| ARNI | 27 (6.63) |
| BB | 368 (90.42) |
| Metoprolol | 182 (44.7) |
| Carvedilol | 186 (45.7) |
| MRA | 335 (82.31) |
| Spironolactone | 277 (68.05) |
| Eplerenone | 58 (14.25) |
| GDMT (All 3 of ACE/ARB, BB and MRA) | 260 (63.8) |
- Citation: Gailson L, Singh A, Pradhan A, Prajapathi S, Choudhary R, Bhandari M, Vishwakarma P, Shukla A, Sharma A, Chaudhary G, Chandra S, Sethi R, Dwivedi SK. Demographic and clinical profile of patients with heart failure at a tertiary care hospital. World J Cardiol 2026; 18(4): 117928
- URL: https://www.wjgnet.com/1949-8462/full/v18/i4/117928.htm
- DOI: https://dx.doi.org/10.4330/wjc.v18.i4.117928